Clinical Signs for DVT
- exam may be unreliable but positive findings should not be ignored
- calf tenderness, swelling, fever, & increased pulse rate may be present
- suggestive exam features for pulmonary embolism
- sudden decrease in O2 saturation
- tachypnea, cyanosis, and hypoxia
- pulmonary consolidation, pleural effusion, wheeze, and cor pulmonale
- new onset tachydysrhythmia (usually atrial fibrillation)
- Risk Reduction
- NICE recommends rivaroxaban (Xarelto®) to prevent blood clots in people who have had a heart attack - NICE 3/25/15
- Bayer Discloses Encouraging Data on Anticoagulant Xarelto
- Bayer happy with Rivaroxaban (Xarelto®) trial results
- New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
- Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.
- Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients
- Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
- Images in Clinical Medicine. Phlegmasia Cerulea Dolens.
- Clinical problem-solving. A sinister development--a 35-year-old woman presented to the emergency department with a 2-day history of progressive swelling and pain in her left leg, without antecedent trauma.